Johns Hopkins Medicine Joins Top US Hospitals to Encourage Everyone to #MaskUp

Growing numbers of COVID-19 cases and deaths are troubling; face masks can slow the trend
Johns Hopkins Medicine

Newswise — Johns Hopkins Medicine, together with 100 of the nation’s top health care systems, representing thousands of hospitals in communities across the U.S., have come together with an urgent plea for all Americans — mask up, because wearing a face mask is one of the best ways to slow the surging COVID-19 pandemic.

With cases of COVID-19 rising across the nation, it’s more vital than ever for us to join this public health campaign to spread the word about the importance of mask-wearing, among other public health measures such as physical distancing and proper hand-washing.

More than 11.5 million Americans have tested positive for the virus, leading to nearly 250,000 deaths. The next several months will be critical. Though there has been positive news about vaccine development, it’s still unclear when those vaccines will be ready for widespread use. In the meantime, everyone must remain vigilant, take precautions and follow public health recommendations.

By working collaboratively with other health systems, we hope to curb the spread of the virus that causes COVID-19 and get through this together.

OUR EXPERTS

The following experts are available for interviews to discuss the importance of wearing a mask and other public health measures that can help stop the spread of COVID-19.

 

MILSTONE aaron 002 (002).jpg

Aaron M. Milstone, M.D., M.H.S., associate professor of pediatrics at the Johns Hopkins University School of Medicine

ROCK clare (002).jpg

Clare Rock, M.B.B.CH., assistant professor of medicine at the Johns Hopkins University School of Medicine

MARAGAKIS lisa 002 (002).jpg

Lisa Maragakis, M.D., M.P.H., senior director of infection prevention at The Johns Hopkins Health System

KELEN Gabor 001 (002).jpg

Gabor Kelen, M.D., director of the Department of Emergency Medicine and professor of emergency medicine at the Johns Hopkins University School of Medicine


For information from Johns Hopkins Medicine about the coronavirus pandemic, visit 
hopkinsmedicine.org/coronavirus. For information on the coronavirus from other Johns Hopkins sources, including the Johns Hopkins Bloomberg School of Public Health and The Johns Hopkins University, visit coronavirus.jhu.edu.

 



Filters close

Showing results

110 of 6112
Newswise: New Study Details Enzyme That Allows Coronavirus to Resist Antiviral Medications
Released: 3-Aug-2021 12:20 PM EDT
New Study Details Enzyme That Allows Coronavirus to Resist Antiviral Medications
Iowa State University

A new Iowa State University study details the structure of a critical enzyme present in SARS-CoV-2, the coronavirus that causes COVID-19. This enzyme removes nucleoside antiviral medications from the virus’s RNA, rendering many treatments ineffective. Scientists could use data uncovered in the new study to find ways to inhibit the enzyme, possibly leading to more effective treatments.

Released: 2-Aug-2021 6:05 PM EDT
Rethinking Remdesivir
University of California San Diego Health

UC San Diego researchers modify remdesivir, creating oral version that can be taken earlier in COVID-19 diagnoses. In cell and animal studies, revised drug proved effective and safe.

Newswise: Researchers from Hackensack Meridian University Medical Center and Colleagues Develop New Model to Help Clinicians Predict Risk of Death in Patients Hospitalized with COVID-19
Released: 2-Aug-2021 4:25 PM EDT
Researchers from Hackensack Meridian University Medical Center and Colleagues Develop New Model to Help Clinicians Predict Risk of Death in Patients Hospitalized with COVID-19
Hackensack Meridian Health

New COVID-19 40-day mortality risk model, published in The Public Library of Science ONE, has potential for use in patient treatment planning, comparisons of therapeutic strategies, and public-health preparations.

Released: 2-Aug-2021 4:05 PM EDT
Town Hall on Effectiveness of COVID-19 Vaccination in Immunosuppressed Patients Hosted by the American College of Rheumatology
American College of Rheumatology (ACR)

How effective COVID-19 vaccines have been in immunosuppressed and rheumatic disease patients remains an incompletely answered question. The American College of Rheumatology (ACR) has organized an expert panel to share what we are learning from real-world data and answer questions.

Released: 2-Aug-2021 2:00 PM EDT
CDC withdrawing its request for emergency use authorization for its COVID-19 PCR diagnostic test does not mean the test failed
Newswise

Social media is now rife with claims about why the CDC is withdrawing its request for emergency use authorization for its COVID-19 PCR diagnostic test after December 2021.

Newswise: Existing Drug Is Shown to Inhibit Virus That Causes COVID-19
Released: 2-Aug-2021 1:30 PM EDT
Existing Drug Is Shown to Inhibit Virus That Causes COVID-19
Argonne National Laboratory

Scientists using the Advanced Photon Source have discovered that a drug used to fight tumors in animals might be effective against many types of coronaviruses, including SARS-CoV-2.

Released: 2-Aug-2021 11:25 AM EDT
Award-Winning Journalist and CDC Principal Investigator to Serve as ACR Convergence 2021 Keynote Speaker
American College of Rheumatology (ACR)

Convergence 2021, the annual meeting of the American College of Rheumatology (ACR), returns to a virtual meeting platform Nov. 1 - 10. This year’s meeting will include presentations from over 320 clinicians, researchers and health experts, including this year’s keynote speaker, Dr. Seema Yasmin.

Newswise: COVID-19: Small Sign of Hope as Vaccinations Rise
Released: 2-Aug-2021 10:45 AM EDT
COVID-19: Small Sign of Hope as Vaccinations Rise
Cedars-Sinai

As COVID-19 cases spike in Los Angeles and throughout the Golden State, driven by the spread of the delta variant among unvaccinated residents, there may be a small sign of hope: More people are finally getting their shot.

Newswise: New Evidence Shows the COVID-19 Delta Variant Rapidly Rising
Released: 31-Jul-2021 10:05 AM EDT
New Evidence Shows the COVID-19 Delta Variant Rapidly Rising
University of Miami Health System, Miller School of Medicine

The University’s coronavirus sequencing effort uncovered that there are several variants present in its patient population, but Delta is chief among them and easily transmitted. And its presence is likely triggering a local surge in the infectious disease. University of Miami researchers and physicians are seeing firsthand how rapidly the Delta variant of COVID-19 is spreading through the local population.


Showing results

110 of 6112

close
1.56169